These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 8196231)
1. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure]. Narita M; Kurihara T; Murano K; Usami M; Honda M Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231 [TBL] [Abstract][Full Text] [Related]
2. [Myocardial imaging with 123I-metaiodobenzylguanidine (123I-MIBG) in essential hypertension: does the 123I-MIBG imaging have the ability to predict its prognosis?]. Narita M; Kurihara T; Murano K; Usami M; Honda M Kaku Igaku; 1994 Aug; 31(8):879-89. PubMed ID: 7933677 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous assessment of regional adrenergic activity and perfusion with 123I-MIBG and 201Tl in congestive heart failure. Seto H; Shimizu M; Nozawa T; Yoshida N; Inagaki S; Kageyama M; Kakishita M Nucl Med Commun; 1996 Mar; 17(3):225-30. PubMed ID: 8692490 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of I-123 MIBG myocardial scintigraphy for evaluating the severity of congestive heart failure]. Morozumi T; Ishida Y; Tani A; Sato H; Matsuyama T; Ozaki H; Hori M; Kitabatake A; Kamada T; Kimura K Kaku Igaku; 1991 Mar; 28(3):271-80. PubMed ID: 2046182 [TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease]. Terada K; Sugihara H; Shiga K; Ohtsuki K; Ito K; Taniguchi Y; Azuma A; Kohno Y; Miyao K; Nakagawa M J Cardiol; 1995 May; 25(5):247-53. PubMed ID: 7776194 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?]. Narita M; Kurihara T J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388 [TBL] [Abstract][Full Text] [Related]
8. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP]. Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352 [TBL] [Abstract][Full Text] [Related]
10. Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference. Somsen GA; Borm JJ; de Milliano PA; van Vlies B; Dubois EA; van Royen EA Eur J Nucl Med; 1995 Oct; 22(10):1149-54. PubMed ID: 8542899 [TBL] [Abstract][Full Text] [Related]
11. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J; J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of myocardial 123I-BMIPP imaging in patients with congestive heart failure without coronary artery disease]. Narita M; Kurihara T; Sindoh T; Sawada Y; Honda M Kaku Igaku; 1998 Apr; 35(4):229-37. PubMed ID: 9642933 [TBL] [Abstract][Full Text] [Related]
13. ¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity. Verschure DO; de Wit TC; Bongers V; Hagen PJ; Sonneck-Koenne C; D'Aron J; Huber K; van Eck-Smit BL; Knoll P; Somsen GA; Mirzaei S; Verberne HJ Nucl Med Commun; 2015 Mar; 36(3):279-85. PubMed ID: 25415845 [TBL] [Abstract][Full Text] [Related]
14. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function. Nagamachi S; Jinnouchi S; Kurose T; Ohnishi T; Flores LG; Nakahara H; Futami S; Tamura S; Matsukura S Ann Nucl Med; 1998 Dec; 12(6):323-31. PubMed ID: 9972369 [TBL] [Abstract][Full Text] [Related]
15. The significance of 123I-BMIPP delayed scintigraphic imaging in cardiac patients. Akashi YJ; Kida K; Suzuki K; Inoue K; Kawasaki K; Yamauchi M; Musha H; Anker SD Int J Cardiol; 2007 Apr; 117(2):145-51. PubMed ID: 16843549 [TBL] [Abstract][Full Text] [Related]
16. Clinical relationship of myocardial sympathetic nervous activity to cardiovascular functions in chronic heart failure: assessment by myocardial scintigraphy with 123I-metaiodobenzylguanidine. Wada Y; Miura M; Fujiwara S; Mori S; Seiji K; Kimura T Tohoku J Exp Med; 2003 Dec; 201(4):261-70. PubMed ID: 14690018 [TBL] [Abstract][Full Text] [Related]
17. Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies. Somsen GA; Borm JJ; Dubois EA; Schook MB; Van Der Wall EE; Van Royen EA Nucl Med Commun; 1996 Oct; 17(10):872-6. PubMed ID: 8951908 [TBL] [Abstract][Full Text] [Related]
18. Iodine-123-metaiodobenzylguanidine myocardial imaging in patients with right ventricular pressure overload. Morimitsu T; Miyahara Y; Sinboku H; Ikeda S; Naito T; Nishijima K; Takao M J Nucl Med; 1996 Aug; 37(8):1343-6. PubMed ID: 8708768 [TBL] [Abstract][Full Text] [Related]
19. Scintigraphic assessment of silent myocardial ischaemia after early infarction using myocardial SPET imaging with 201Tl and 123I-MIBG. Shimonagata T; Ishida Y; Hayashida K; Takamiya M; Uehara T; Nishimura T Nucl Med Commun; 1995 Nov; 16(11):893-900. PubMed ID: 8587753 [TBL] [Abstract][Full Text] [Related]
20. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy. Simmons WW; Freeman MR; Grima EA; Hsia TW; Armstrong PW Circulation; 1994 Jun; 89(6):2843-51. PubMed ID: 8205700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]